Cambridge Epigenetix fetches $88m Series D
Cambridge Epigenetix, a life sciences tools and technology company, has raised $88 million in Series D financing.
Cambridge Epigenetix, a life sciences tools and technology company, has raised $88 million in Series D financing.
Copyright PEI Media
Not for publication, email or dissemination